id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-275903-sfrpfy5g	Yu, Fenggang	The other side of the coin: Leveraging Epstein–Barr virus in research and therapy	2016-07-21		.txt	text/plain	4468	220	39	In this article, we will discuss the utility of targeting EBV gene products, the viral episome, and whole virus for research, screening, diagnostic, and future treatment of NPC ( Fig. 1 ). Given the non-integrative characteristic of the EBV episome and its ability to accommodate large transgene insertion, the use of EBV episomal vector had been extended to genetic studies, protein production, gene therapy, and iPSCs generation. Epstein-Barr virus vector-mediated gene transfer into human B cells: potential for antitumor vaccination Highly efficient suicide gene expression in hepatocellular carcinoma cells by Epstein-Barr virus-based plasmid vectors combined with polyamidoamine dendrimer Adoptive transfer of allogeneic Epstein-Barr virus (EBV)-specific cytotoxic T cells with in vitro antitumor activity boosts LMP2-specific immune response in a patient with EBV-related nasopharyngeal carcinoma Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma Plasma Epstein-Barr virus (EBV) DNA: role as a screening test for nasopharyngeal carcinoma (NPC)?	./cache/cord-275903-sfrpfy5g.txt	./txt/cord-275903-sfrpfy5g.txt